ProShares UltraShort Valuation
| RXD Etf | USD 10.48 0.10 0.95% |
At this time, the etf appears to be overvalued. ProShares UltraShort holds a recent Real Value of $9.59 per share. The prevailing price of the etf is $10.48. Our model determines the value of ProShares UltraShort from analyzing the etf fundamentals such as Number Of Employees of 10, net asset of 9.15 M, and One Year Return of (15.20) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ProShares UltraShort's price fluctuation is not too volatile at this time. Calculation of the real value of ProShares UltraShort is based on 3 months time horizon. Increasing ProShares UltraShort's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ProShares etf is determined by what a typical buyer is willing to pay for full or partial control of ProShares UltraShort Health. Since ProShares UltraShort is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProShares Etf. However, ProShares UltraShort's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.48 | Real 9.59 | Hype 10.48 | Naive 10.09 |
The real value of ProShares Etf, also known as its intrinsic value, is the underlying worth of ProShares UltraShort ETF, which is reflected in its stock price. It is based on ProShares UltraShort's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ProShares UltraShort's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ProShares UltraShort Health helps investors to forecast how ProShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProShares UltraShort more accurately as focusing exclusively on ProShares UltraShort's fundamentals will not take into account other important factors: Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ProShares UltraShort's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ProShares UltraShort and how it compares across the competition.
About ProShares UltraShort Valuation
The etf valuation mechanism determines ProShares UltraShort's current worth on a weekly basis. Our valuation model uses a comparative analysis of ProShares UltraShort. We calculate exposure to ProShares UltraShort's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProShares UltraShort's related companies.The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. Ultrashort Health is traded on NYSEARCA Exchange in the United States.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProShares UltraShort Health. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
The market value of ProShares UltraShort is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares UltraShort's value that differs from its market value or its book value, called intrinsic value, which is ProShares UltraShort's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares UltraShort's market value can be influenced by many factors that don't directly affect ProShares UltraShort's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares UltraShort's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares UltraShort is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares UltraShort's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.